Long-term outcomes of the intravitreal injection of ranibizumab for the treatment of choroidal neovascularization secondary to pathologic myopia

被引：0
|
作者：
Ewa Wasiluk
Malgorzata Wojnar
Iwona Obuchowska
Zofia Mariak
机构：
[1] The Medical University of Bialystok Clinical Hospital,Department of Ophthalmology
来源：
International Ophthalmology | 2020年 / 40卷
关键词：
Myopic CNV; Intravitreal anti-VEGF; Ranibizumab; Pathologic myopia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：833 / 839
页数：6
相关论文
共 50 条
  • [1] Long-term outcomes of the intravitreal injection of ranibizumab for the treatment of choroidal neovascularization secondary to pathologic myopia
    Wasiluk, Ewa
    Wojnar, Malgorzata
    Obuchowska, Iwona
    Mariak, Zofia
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (04) : 833 - 839
  • [2] INTRAVITREAL RANIBIZUMAB FOR THE PRIMARY TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA
    Lai, Timothy Y. Y.
    Chan, Wai-Man
    Liu, David T. L.
    Lam, Dennis S. C.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (06): : 750 - 756
  • [3] Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes
    Valentina Sarao
    Daniele Veritti
    Sara Macor
    Paolo Lanzetta
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 445 - 454
  • [4] Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes
    Sarao, Valentina
    Veritti, Daniele
    Macor, Sara
    Lanzetta, Paolo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (03) : 445 - 454
  • [5] INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION COMPLICATING PATHOLOGIC MYOPIA
    Lalloum, Franck
    Souied, Eric H.
    Bastuji-Garin, Sylvie
    Puche, Nathalie
    Querques, Giuseppe
    Glacet-Bernard, Agnes
    Coscas, Gabriel
    Soubrane, Gisele
    Leveziel, Nicolas
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (03): : 399 - 406
  • [6] Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results
    J M Monés
    L Amselem
    A Serrano
    M Garcia
    M Hijano
    Eye, 2009, 23 : 1275 - 1281
  • [7] Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results
    Mones, J. M.
    Amselem, L.
    Serrano, A.
    Garcia, M.
    Hijano, M.
    EYE, 2009, 23 (06) : 1276 - 1280
  • [8] FIVE-YEAR OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA
    Onishi, Yuka
    Yokoi, Tae
    Kasahara, Kaori
    Yoshida, Takeshi
    Nagaoka, Natsuko
    Shinohara, Kosei
    Kaneko, Yuichiro
    Suga, Mitsuki
    Uramoto, Kengo
    Ohno-Tanaka, Akiko
    Ohno-Matsui, Kyoko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (07): : 1289 - 1298
  • [9] Intravitreal ranibizumab therapy for choroidal neovascularization secondary to pathological myopia
    Regina, Lukacs
    Gabor, Sandor
    Miklos, Resch
    Antal, Szabo
    Gyorgy, Barcsay
    Monika, Ecsedy
    Zsuzsanna, Szepessy
    Zsolt, Nagy Zoltan
    Andras, Papp
    ORVOSI HETILAP, 2017, 158 (15) : 579 - 586
  • [10] Comparison of Intravitreal Bevacizumab versus Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Secondary to Pathologic Myopia-6 Month Results
    Fonseca, S.
    Carneiro, A.
    Mendonca, L.
    Falcao, M.
    Branclao, E.
    Falcao-Reis, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
12345